9.3.2 Targeted Cancer Therapies.docx

8/11/2019 9.3.2 Targeted Cancer Therapies.docx

1/8
http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046092&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045961&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046092&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045693&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000741769&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044020&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046479&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000756173&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045214&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044078&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045065&version=Patient&language=English


2/8


3/8
http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046066&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046356&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044222&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044222&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044697&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000538149&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045020&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045705&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045772&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044124&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000597170&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000597170&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045713&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046622&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045729&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046739&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046524&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000537335&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000537335&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044829&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045110&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000698772&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000470256&version=Patient&language=English


4/8
http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044521&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044133&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045859&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044945&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045812&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000444971&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045382&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045439&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045214&version=Patient&language=Englishhttp://www.cancer.gov/cancertopics/factsheet/Therapy/targeted#r1http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045669&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000721263&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045135&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044643&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000561720&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000561720&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000270742&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046063&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000416101&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000285970&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045693&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045693&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000561237&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044382&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000270742&version=Patient&language=Englishhttp://www.cancer.gov/cancertopics/factsheet/Therapy/biologicalhttp://www.cancer.gov/cancertopics/factsheet/Therapy/cancer-vaccineshttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045353&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044952&version=Patient&language=English


5/8
http://www.cancer.gov/cancertopics/druginfo/everolimushttp://www.cancer.gov/cancertopics/druginfo/bevacizumabhttp://www.cancer.gov/cancertopics/druginfo/vismodegibhttp://www.cancer.gov/cancertopics/druginfo/trastuzumabhttp://www.cancer.gov/cancertopics/druginfo/trastuzumabhttp://www.cancer.gov/cancertopics/factsheet/Therapy/targeted#r4http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045727&version=Patient&language=Englishhttp://www.cancer.gov/cancertopics/factsheet/Therapy/targeted#r3http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046115&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046739&version=Patient&language=Englishhttp://www.cancer.gov/cancertopics/factsheet/Therapy/targeted#r2http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045680&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045680&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000258356&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000508929&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044829&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044829&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044183&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000467853&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000476017&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046371&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000306496&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046580&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045214&version=Patient&language=English


6/8
http://www.cancer.gov/cancertopics/druginfo/pomalidomidehttp://www.cancer.gov/cancertopics/druginfo/lenalidomidehttp://www.cancer.gov/cancertopics/druginfo/lenalidomidehttp://www.cancer.gov/cancertopics/druginfo/carfilzomibhttp://www.cancer.gov/cancertopics/druginfo/bortezomibhttp://www.cancer.gov/cancertopics/druginfo/fda-pembrolizumabhttp://www.cancer.gov/cancertopics/druginfo/dabrafenibhttp://www.cancer.gov/cancertopics/druginfo/trametinibhttp://www.cancer.gov/cancertopics/druginfo/trametinibhttp://www.cancer.gov/cancertopics/druginfo/vemurafenibhttp://www.cancer.gov/cancertopics/druginfo/ipilimumabhttp://www.cancer.gov/cancertopics/druginfo/belinostathttp://www.cancer.gov/cancertopics/druginfo/belinostathttp://www.cancer.gov/drugdictionary?CdrID=601486http://www.cancer.gov/drugdictionary?CdrID=475765http://www.cancer.gov/cancertopics/druginfo/ibrutinibhttp://www.cancer.gov/cancertopics/druginfo/lenalidomidehttp://www.cancer.gov/cancertopics/druginfo/lenalidomidehttp://www.cancer.gov/cancertopics/druginfo/pralatrexatehttp://www.cancer.gov/cancertopics/druginfo/bortezomibhttp://www.cancer.gov/cancertopics/druginfo/bexarotenehttp://www.cancer.gov/cancertopics/druginfo/bexarotenehttp://www.cancer.gov/cancertopics/druginfo/romidepsinhttp://www.cancer.gov/cancertopics/druginfo/vorinostathttp://www.cancer.gov/cancertopics/druginfo/rituximabhttp://www.cancer.gov/cancertopics/druginfo/rituximabhttp://www.cancer.gov/cancertopics/druginfo/brentuximabvedotinhttp://www.cancer.gov/cancertopics/druginfo/denileukindiftitoxhttp://www.cancer.gov/cancertopics/druginfo/ibritumomabtiuxetanhttp://www.cancer.gov/cancertopics/druginfo/ibritumomabtiuxetanhttp://www.cancer.gov/cancertopics/druginfo/tositumomab-I131tositumomabhttp://www.cancer.gov/drugdictionary?CdrID=694589http://www.cancer.gov/drugdictionary?CdrID=537572http://www.cancer.gov/cancertopics/druginfo/gefitinibhttp://www.cancer.gov/cancertopics/druginfo/gefitinibhttp://www.cancer.gov/cancertopics/druginfo/erlotinibhydrochloridehttp://www.cancer.gov/cancertopics/druginfo/crizotinibhttp://www.cancer.gov/cancertopics/druginfo/bevacizumabhttp://www.cancer.gov/cancertopics/druginfo/sorafenibtosylatehttp://www.cancer.gov/drugdictionary?CdrID=601486http://www.cancer.gov/cancertopics/druginfo/ibrutinibhttp://www.cancer.gov/cancertopics/druginfo/ibrutinibhttp://www.cancer.gov/cancertopics/druginfo/obinutuzumabhttp://www.cancer.gov/cancertopics/druginfo/ofatumumabhttp://www.cancer.gov/cancertopics/druginfo/alemtuzumabhttp://www.cancer.gov/cancertopics/druginfo/alemtuzumabhttp://www.cancer.gov/cancertopics/druginfo/rituximabhttp://www.cancer.gov/cancertopics/druginfo/bosutinibhttp://www.cancer.gov/cancertopics/druginfo/nilotinibhttp://www.cancer.gov/cancertopics/druginfo/dasatinibhttp://www.cancer.gov/cancertopics/druginfo/dasatinibhttp://www.cancer.gov/cancertopics/druginfo/imatinibmesylatehttp://www.cancer.gov/drugdictionary/?CdrID=41258http://www.cancer.gov/cancertopics/druginfo/axitinibhttp://www.cancer.gov/cancertopics/druginfo/axitinibhttp://www.cancer.gov/cancertopics/druginfo/everolimushttp://www.cancer.gov/cancertopics/druginfo/temsirolimushttp://www.cancer.gov/cancertopics/druginfo/pazopanibhydrochloridehttp://www.cancer.gov/cancertopics/druginfo/sunitinibmalatehttp://www.cancer.gov/cancertopics/druginfo/sunitinibmalatehttp://www.cancer.gov/cancertopics/druginfo/sorafenibtosylatehttp://www.cancer.gov/cancertopics/druginfo/bevacizumabhttp://www.cancer.gov/drugdictionary/?CdrID=42147http://www.cancer.gov/cancertopics/druginfo/denosumabhttp://www.cancer.gov/cancertopics/druginfo/regorafenibhttp://www.cancer.gov/cancertopics/druginfo/sunitinibmalatehttp://www.cancer.gov/cancertopics/druginfo/sunitinibmalatehttp://www.cancer.gov/cancertopics/druginfo/imatinibmesylatehttp://www.cancer.gov/cancertopics/druginfo/cetuximabhttp://www.cancer.gov/cancertopics/druginfo/imatinibmesylatehttp://www.cancer.gov/cancertopics/druginfo/regorafenibhttp://www.cancer.gov/cancertopics/druginfo/ziv-aflibercepthttp://www.cancer.gov/cancertopics/druginfo/bevacizumabhttp://www.cancer.gov/cancertopics/druginfo/bevacizumabhttp://www.cancer.gov/cancertopics/druginfo/panitumumabhttp://www.cancer.gov/cancertopics/druginfo/cetuximabhttp://www.cancer.gov/cancertopics/druginfo/bevacizumabhttp://www.cancer.gov/cancertopics/druginfo/ado-trastuzumab-emtansinehttp://www.cancer.gov/cancertopics/druginfo/ado-trastuzumab-emtansinehttp://www.cancer.gov/drugdictionary?CdrID=322808http://www.cancer.gov/cancertopics/druginfo/letrozolehttp://www.cancer.gov/cancertopics/druginfo/lapatinibditosylatehttp://www.cancer.gov/cancertopics/druginfo/exemestanehttp://www.cancer.gov/cancertopics/druginfo/exemestanehttp://www.cancer.gov/cancertopics/druginfo/anastrozolehttp://www.cancer.gov/cancertopics/druginfo/fulvestranthttp://www.cancer.gov/cancertopics/druginfo/trastuzumabhttp://www.cancer.gov/cancertopics/druginfo/trastuzumabhttp://www.cancer.gov/cancertopics/druginfo/toremifenehttp://www.cancer.gov/cancertopics/druginfo/tamoxifencitratehttp://www.cancer.gov/cancertopics/druginfo/everolimus


7/8
http://www.ncbi.nlm.nih.gov/pubmed/23020132http://www.cancer.gov/clinicaltrials/search/results?protocolsearchid=12731216http://www.cancer.gov/clinicaltrials/search/results?protocolsearchid=12000577http://www.cancer.gov/clinicaltrials/search/results?protocolsearchid=12731205http://www.cancer.gov/clinicaltrials/search/results?protocolsearchid=12731198http://www.cancer.gov/clinicaltrials/search/results?protocolsearchid=12731168http://www.cancer.gov/clinicaltrials/search/results?protocolsearchid=12748503http://www.cancer.gov/clinicaltrials/search/results?protocolsearchid=12731149http://www.cancer.gov/clinicaltrials/search-form-helphttp://www.cancer.gov/clinicaltrials/searchhttp://www.cancer.gov/clinicaltrials/searchhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045961&version=Patient&language=Englishhttp://www.cancer.gov/cancertopics/druginfo/sorafenibtosylatehttp://www.cancer.gov/cancertopics/druginfo/sorafenibtosylatehttp://www.cancer.gov/cancertopics/druginfo/vandetanibhttp://www.cancer.gov/cancertopics/druginfo/fda-cabozantinib-s-malatehttp://www.cancer.gov/cancertopics/druginfo/imatinibmesylatehttp://www.cancer.gov/drugdictionary?CdrID=570535http://www.cancer.gov/cancertopics/druginfo/pazopanibhydrochloridehttp://www.cancer.gov/cancertopics/druginfo/radium-223-dichloridehttp://www.cancer.gov/cancertopics/druginfo/abirateroneacetatehttp://www.cancer.gov/cancertopics/druginfo/abirateroneacetatehttp://www.cancer.gov/cancertopics/druginfo/enzalutamidehttp://www.cancer.gov/cancertopics/druginfo/cabazitaxelhttp://www.cancer.gov/cancertopics/druginfo/sunitinibmalatehttp://www.cancer.gov/cancertopics/druginfo/everolimushttp://www.cancer.gov/cancertopics/druginfo/erlotinibhydrochloridehttp://www.cancer.gov/cancertopics/druginfo/imatinibmesylate


8/8
http://www.ncbi.nlm.nih.gov/pubmed/23369685http://www.ncbi.nlm.nih.gov/pubmed/24283603http://www.ncbi.nlm.nih.gov/pubmed/22795701

Documents

9.3.2 Targeted Cancer Therapies.docx